このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Preventing Diabetic Osteoporosis With Exercise (DIABETICBONE)

2019年4月26日 更新者:Dr. Katarina Borer、University of Michigan

Parameters of Exercise to Prevent Type 2 Diabetic Osteoporosis in Postmenopausal Women

The two specific aims of the study were to determine whether:

  1. Greater mechanical loading of downhill exercise will increase the osteogenic index (ratio between CICP, the marker of bone formation (c-terminal propeptide of type I collagen, and CTX, the marker of bone resorption (c terminal telopeptide of type I collagen)) to a greater extent than uphill exercise that provides lower ground-reaction force;
  2. Exercise after the meals will induce greater osteogenic response than exercise pefore the meals as it is known that meal eating during daytime inhibits bvone resorption markers.

調査の概要

詳細な説明

The study addresses the problem that postmenopausal women with type 2 diabetes have a higher incidence of bone breaks despite their often normal bone mineral density (BMD).

The investigators pursued two hypotheses, that:

  1. 40-minute bout of downhill exercise will increase the CICP/CTX osteogenic index to a greater extent than the same amount of uphill exercise; and
  2. Performing exercise one hour after the meals will be more osteogenic than exercise before the meals.

Subjects were 15 postmenopausal women with type 2 diabetes, age 57.7 years, BMI 27.2 kg/m2 who were randomly assigned to two out of 5 trials:

Uphill exercise before the meals (UBM), Uphill exercise after the meals (UAM), Downhill exercise before the meals (DBM), Downhill exercise after the meals (DAM), and Sedentary, no-exercise, trial (SED). All subjects signed an informed consent approved by the University of Michigan Medical School Institutional Review Board. Subjects had their BMD measured with DXA at the outset.

Weight-maintenance meals contained 50% carbohydrate, 15% protein, and 25% fat and were provided at 10 h and 17 h. Exercise (40 minutes at 50% of maximal effort) on either uphill (+6o slope) or downhill treadmill (-6o slope) was performed either before the two meals, at 9 h and 16 h, respectively, or after the meals. at 11 h and 18 h, respectively.

Blood was drawn through an intravenous catheter from ante-cubital vein at hourly intervals between 8 and 20 h with two additional blood draws at 0 h and 6 h the next morning. Blood was treated with protease inhibitors, and plasma, frozen at -80o C, was used to measure bone markers, CICP, CTX, osteocalcin , and bone-specific alkaline phosphatase using Millipore chemoluminescen reagents, glucose by glucose oxidase, and hormones insulin, cortisol, parathyroid hormone (PTH) , and growth hormone (GH) by radio-immunoassays..

Mixed-model ANOVA was used for analysis of outcome measures where the trial procedures served as fixed variable and individual subjects as intercept variables.

研究の種類

介入

入学 (実際)

15

段階

  • 適用できない

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

50年~65年 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

女性

説明

Inclusion Criteria:

postmenopausal type-2 diabetes melllitus age between 50 and 65 exercise less than 20 minutes three times a week

Exclusion Criteria:

metabolic disease other than type-2 diabetes and hormonally-corrected hypothyroidism musculo-skeletal disability that would preclude exercise smoker do not meet inclusion criteria

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:基礎科学
  • 割り当て:ランダム化
  • 介入モデル:階乗代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Uphill exercise before the meals
40 minutes of uphill treadmill exercise at +6o slope completed 1 hour before eating the meal
40 minutes of uphill exercise
40 minutes of uphill exercise completed 1 h before the meal
40 minutes of downhill exercise completed 1 hour before the meal
実験的:Uphill exercise after the meals
40 minutes of uphill treadmill exercise at +6o slope started 1 hour after eating the meal
40 minutes of uphill exercise
40 minutes of uphill exercise started 1 hour after gthe meal
40 minutes of downhill exercise started 1 hour after the meal
実験的:Downhill exercise before the meals
40 minutes of downhill treadmill exercise at -6o slope completed 1 hour before eating the meal
40 minutes of uphill exercise completed 1 h before the meal
40 minutes of downhill exercise completed 1 hour before the meal
40 minutes of downhill exercise
実験的:Downhill exercise after the meals
40 minutes of downhill treadmill exercise at -6o slope started 1 hour after eating the meal
40 minutes of uphill exercise started 1 hour after gthe meal
40 minutes of downhill exercise started 1 hour after the meal
40 minutes of downhill exercise
偽コンパレータ:Sedentary trial
A trial with no exercise
Sedentary no-exercise trial
Meals eaten at 10 and 17 h during a sedentary trial

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
C-terminal propeptide of type I collagen
時間枠:Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial
Change over time in plasma concentration of c-terminal propeptde of type 1 collagen (ng/ml)
Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial
C-terminal telopeptide of type 1 collagen
時間枠:Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial
Change over time in plasma concentration of c-terminal telopeptide of type 1 collagen (ng/ml)
Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial
Osteocalcin
時間枠:Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial
Change over time in plasma concentration of osteocalcin (ng/ml)
Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial
Bone-specific alkaline phosphatase
時間枠:Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial
Change over time in plasma concentration of bone-specific alkaline phosphatase (ng/ml)
Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial

二次結果の測定

結果測定
メジャーの説明
時間枠
Insulin
時間枠:Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial
Change over time in plasma concentration of insulin (µU/ml)
Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial
Parathyroid hormone
時間枠:Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial
Change over time in plasma concentration of parathyroid hormone (ng/ml)
Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial
Cortisol
時間枠:Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial
Change over time in plasma concentration of cortisol (m/L)
Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial
Growth hormone
時間枠:Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial
Change over time in plasma concentration of growth hormone (ng/ml)
Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial
Glucose
時間枠:Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial
Change over time in plasma concentration of glucose (mg/dl)
Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial
Dual-energy X-ray radiography
時間枠:A week prior to the study baseline
Whole-body dual-energy X-ray radiography scan
A week prior to the study baseline
Novel Pedar
時間枠:During two one-hour bouts of the exercise intervention
Mechanosensitive shoe inserts for measurement of ground reaction force
During two one-hour bouts of the exercise intervention

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Katarina T Borer、Professor Emerita

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2009年10月8日

一次修了 (実際)

2012年12月5日

研究の完了 (実際)

2012年12月20日

試験登録日

最初に提出

2019年4月19日

QC基準を満たした最初の提出物

2019年4月26日

最初の投稿 (実際)

2019年4月29日

学習記録の更新

投稿された最後の更新 (実際)

2019年4月29日

QC基準を満たした最後の更新が送信されました

2019年4月26日

最終確認日

2019年4月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • HUM32227/ HUM32700
  • R15DK082800 (米国 NIH グラント/契約)
  • M01RR024986 (その他の助成金/資金番号:Michigan Institute of Clinical and Health Research)

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する